Coherus BioSciences
CHRS
#8354
Rank
HK$1.96 B
Marketcap
HK$12.76
Share price
-4.40%
Change (1 day)
99.44%
Change (1 year)

Market capitalization of Coherus BioSciences (CHRS)

Market cap: HK$1.96 Billion

As of May 2026 Coherus BioSciences has a market cap of HK$1.96 Billion. This makes Coherus BioSciences the world's 8354th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Coherus BioSciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.96 B57.38%
2025HK$1.25 B-6.15%
2024HK$1.33 B-53.98%
2023HK$2.89 B-39.82%
2022HK$4.81 B-49.63%
2021HK$9.55 B-1.56%
2020HK$9.70 B-1.62%
2019HK$9.86 B103.84%
2018HK$4.84 B19.9%
2017HK$4.03 B-57.63%
2016HK$9.52 B37.28%
2015HK$6.94 B64.88%
2014HK$4.20 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of Coherus BioSciences was reported to be:

HK$2.05 Billion
by Nasdaq info icon info icon
HK$2.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.421 T 72,113.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$45.65 B 2,219.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.42 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.27 B 2,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA